These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 21615563

  • 1. Mechanisms of glucocorticoids in the control of neuroinflammation.
    Schweingruber N, Reichardt SD, Lühder F, Reichardt HM.
    J Neuroendocrinol; 2012 Jan; 24(1):174-82. PubMed ID: 21615563
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM, Gold R, Lühder F.
    Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L, Annunziata P, Sessa E, Bramanti P.
    J Neurol Sci; 2009 Dec 15; 287(1-2):17-26. PubMed ID: 19758606
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis.
    Hoepner R, Bagnoud M, Pistor M, Salmen A, Briner M, Synn H, Schrewe L, Guse K, Ahmadi F, Demir S, Laverick L, Gresle M, Worley P, Reichardt HM, Butzkueven H, Gold R, Metz I, Lühder F, Chan A.
    Acta Neuropathol; 2019 Sep 15; 138(3):443-456. PubMed ID: 31030237
    [Abstract] [Full Text] [Related]

  • 11. [Action mechanism of synthetic glucocorticoids].
    Yanase T, Nawata H.
    Nihon Rinsho; 1994 Mar 15; 52(3):578-82. PubMed ID: 8164352
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoid receptor in human respiratory epithelial cells.
    Pujolsa L, Mullol J, Picado C.
    Neuroimmunomodulation; 2009 Mar 15; 16(5):290-9. PubMed ID: 19571590
    [Abstract] [Full Text] [Related]

  • 13. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
    Löwenberg M, Stahn C, Hommes DW, Buttgereit F.
    Steroids; 2008 Oct 15; 73(9-10):1025-9. PubMed ID: 18221974
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glucocorticoids in T cell apoptosis and function.
    Herold MJ, McPherson KG, Reichardt HM.
    Cell Mol Life Sci; 2006 Jan 15; 63(1):60-72. PubMed ID: 16314919
    [Abstract] [Full Text] [Related]

  • 18. Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells.
    Boldizsar F, Talaber G, Szabo M, Bartis D, Palinkas L, Nemeth P, Berki T.
    Immunobiology; 2010 Jul 15; 215(7):521-6. PubMed ID: 19906460
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index.
    Schäcke H, Rehwinkel H, Asadullah K, Cato AC.
    Exp Dermatol; 2006 Aug 15; 15(8):565-73. PubMed ID: 16842594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.